Vetbiolix
vetbiolix.com
Actively hiring
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1–2
French register · Dec 2023
Backers
1
Band of Angels
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 9, 2025
Increased its share capital $79k · BODACC
Jun 21, 2022
Increased its share capital $51k · BODACC
Jan 18, 2022
Increased its share capital $35k · BODACC
Mar 28, 2018
Founded per the company register
Registers and programsofficial lists and records that name the company
| Legal entity | VETBIOLIX | recherche-entreprises |
| Registered | 28 Mar 2018 |
Founders and leadersfrom filings, registers and the company's site
Matthieu DubruqueDirecteur Généralcompany register
Matthieu RoquettePrésident de SAScompany register
Backed byfrom the funds' portfolios and accelerator catalogs
Band of Angels Similar startupsby what they do, their industry and backers
SignaCor, a UK based, clinical stage biotech company are pioneering a first-in-class therapeutic approach to symptomatic hypertrophic…
Therapeutic Ultrasound-Based Solution for Vascular Care. cardiovascular disease is VTE. ¹.
Products for veterinarians. Diagnostic mail-in test kits and instruments for cats and dogs. Cytology, urinalysis, fecal, culture &…
Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting…
Moichor’s Pathview device revolutionizes veterinary diagnostics for dogs, cats, and all species, providing rapid AI-powered hematology and…
Developing the next generation of left-heart access technologies.
News
Can-Fite's Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026
Can-Fite Signed a Deal Worth up to $325M with the Veterinary Company Vetbiolix Ramat Gan, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary sm
Read more
Report
Medivir AB: Medivir's partner Vetbiolix announces initiation of randomized, placebo-controlled study to confirm clinical benefit with VBX-1000 (MIV-701)
Speedy inclusion of the first 10 dogs, out of a total of 51, within one month of study startTop-line data expected by Q4 2026Blockbuster potential as the first disease-modifying therapy to halt bone loss
Read more
Report
Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market
--Can-Fite BioPharma Ltd., a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced that its veterinary partner Vetbiolix is initiating an advanced clinical study in
Read more
Report
Projected Income of $325M to Can-Fite Over the Next 10 Years After Vetbiolix Exercised its Option and Licensed Piclidenoson for Veterinary Osteoarthritis
The agreement has been signed upon successful conclusion of a clinical study in dogs with osteoarthritis RAMAT GAN, Israel, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a p
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Matthieu Dubruque
Directeur Général
Matthieu Roquette
Président de SAS
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Loos
France
HQ
Discuss together new solutions foranimal health
1-10 est. staff
350, Avenue Eugène Avinée, 59120, Loos – France